EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Outcomes and Risk Factors in Vasoplegic Patients Following Left Ventricular Assist Device Implantation

Darrick A Emery, Stephanie Ciapala, J Bradley Williams, Sanjeeb Bhattacharya, Andrew Higgins, Ran Lee, Pavan Bhat, Edward Soltesz, Michael Z Tong, Benjamin Hohlfelder

Journal of Cardiothoracic and Vascular Anesthesia · 2026

DOI: 10.1053/j.jvca.2025.09.035 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026. Verfasst von Darrick A Emery und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Duke University Hospital, Durham, NC. Electronic address: darrickemery@gmail.com. Hauptthemen laut MEDLINE: Heart-Assist Devices, Vasoplegia, Postoperative Complications, Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To describe vasoplegia incidence, management strategies, and factors associated with vasoplegia in a HeartMate left ventricular assist device (LVAD) patient population. DESIGN: A retrospective, observational study was performed. The primary outcome was the incidence of vasoplegia (persistent hypotension requiring >0.2 μg/kg/min norepinephrine equivalent for >6 hours) following LVAD implantation. Multivariable logistic regression analysis was conducted to determine factors associated with the development of vasoplegia. A subgroup analysis was performed to compare patients who received and did not receive preoperative renin-angiotensin-aldosterone system inhibitors to evaluate their impact on postoperative vasoplegia. SETTING: A single-center, quaternary care academic medical center. PARTICIPANTS: Adult patients (N = 184) who will undergo LVAD implantation from 2019 to 2022. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The incidence of vasoplegia was 33%. In patients who developed vasoplegia, the median maximum dosage of vasopressors was 0.28 μg/kg/min (0.24-0.34) norepinephrine equivalents with a median duration of 30 hours (18-50) on vasopressors. Mean arterial pressure immediately before the operating room (OR 0.961), duration on cardiopulmonary bypass (OR 1.012), preoperative renal dysfunction (OR 3.185), and postoperative inotrope use (OR 4.857) were independently associated with risk of vasoplegia based on multivariable logistic regression analysis. No differences in rates of vasoplegia were observed based on receipt of preoperative renin-angiotensin-aldosterone system inhibitors. No mortality differences were observed between patients who did versus did not develop vasoplegia. CONCLUSIONS: Vasoplegia following LVAD implantation is a common postoperative complication. Longer duration on cardiopulmonary bypass, preoperative renal dysfunction, and postoperative inotrope use following LVAD implantation were associated with an increased risk of developing postoperative vasoplegia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesVasoplegiaPostoperative ComplicationsHeart FailureHumansMaleRetrospective StudiesFemaleMiddle AgedRisk FactorsIncidenceAgedAdultTreatment Outcome

Stichwörter der Autor:innen

LVAD implantationRAAS inhibitorrisk factorsvasoplegiaβ-blocker

Autor:innen und Institutionen

  • Department of Pharmacy, Duke University Hospital, Durham, NC. Electronic address: darrickemery@gmail.com.
  • Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
  • Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH; Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH.
  • Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH.

Zitieren

APA

Emery, D. A., Ciapala, S., Williams, J. B., Bhattacharya, S., Higgins, A., Lee, R., Bhat, P., Soltesz, E., Tong, M. Z., & Hohlfelder, B. (2026). Outcomes and Risk Factors in Vasoplegic Patients Following Left Ventricular Assist Device Implantation. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2025.09.035

Vancouver

Emery DA, Ciapala S, Williams JB, Bhattacharya S, Higgins A, Lee R, et al. Outcomes and Risk Factors in Vasoplegic Patients Following Left Ventricular Assist Device Implantation. Journal of Cardiothoracic and Vascular Anesthesia. 2026. doi:10.1053/j.jvca.2025.09.035

BibTeX
@article{Emery2026,
  author = {Emery, Darrick A and Ciapala, Stephanie and Williams, J Bradley and Bhattacharya, Sanjeeb and Higgins, Andrew and Lee, Ran and Bhat, Pavan and Soltesz, Edward and Tong, Michael Z and Hohlfelder, Benjamin},
  title = {Outcomes and Risk Factors in Vasoplegic Patients Following Left Ventricular Assist Device Implantation},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2026},
  doi = {10.1053/j.jvca.2025.09.035}
}
Kostenlos starten →